Ernesto Bernal-Mizrachi, M.D., is an associate professor of internal medicine and the Larry D. Soderquist Professor in the University of Michigan Medical School. Dr. Bernal-Mizrachi received his medical degree in 1989 from the Universidad del Valle Medical School in Cali, Colombia, and completed a residency in internal medicine there. He came to the United States in 1993 for additional residency training in internal medicine at the University of Miami, followed by a three-year fellowship in endocrinology and metabolism at Washington University in St. Louis. He joined Washington University faculty in 1999 and held the academic titles of assistant professor of medicine and assistant professor of cell biology from 2004 until he came to Michigan last summer to assume the Soderquist Professorship.

Dr. Bernal-Mizrachi’s research is focused on the regulation of pancreatic beta cell mass and function, with a particular interest in Akt and mTOR signaling in beta cell proliferation. He has an excellent record of grant funding and currently is principal investigator on two RO1 grants from the National Institutes of Health and two foundation grants.

Dr. Bernal-Mizrachi’s teaching and mentoring contributions parallel his interests as a clinician and investigator. He also is recognized for his organizational service contributions, which include session chair of a symposium sponsored by the European Association for the Study of Diabetes and ad hoc reviewer activities for various specialty journals and granting agencies. In addition, he has served on study sections and review panels for the National Institutes of Health and the Juvenile Diabetes Research Foundation. Dr. Bernal-Mizrachi was elected a member of the American Society for Clinical Investigation (ASCI).